| Code | 28454 | ||||||||||
| MA number | 59/0125/99-S | ||||||||||
| Product Form: | sus inj 1x1 ml/20 µg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | LG Life Sciences Poland Spólka Z O.O., Poland | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 11.10.1999 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_Euvax B_20 mcg_november 2016.doc
|
| PIL: |
PIL_Euvax B_20 mcg_november 2016.doc
|
| Safety feature | Yes |
| Data update: | 20.02.2018 |
